abstract |
The present invention relates to novel oxazine derivatives of the formula I and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, combinations thereof and, in particular, medicaments for the treatment of Alzheimer's disease or diabetes through the inhibition of BACE-1 or BACE-2 Lt; / RTI > (I) In this formula, all variables are as defined herein. |